MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2017 International Congress

    Structural and Functional Correlates of Anxiety in Parkinson’s disease.

    F. Růžička, T. Ballarini, O. Bezdíček, J. Roth, T. Sieger, J. Vymazal, E. Růžička, K. Mueller, R. Jech (Prague, Czech Republic)

    Objective: The aim of this study was to investigate the structural and functional correlates of anxiety in PD and healthy controls (HC) applying voxel-based morphometry…
  • 2017 International Congress

    Predicting the onset of freezing of gait: A longitudinal study

    K. Ehgoetz Martens, E. Lukasik, M. Georgiades, M. Gilat, J. Hall, C. Walton, S. Lewis (Camperdown, Australia)

    Objective: This prospective cohort study sought to examine longitudinal data spanning the transition period where PD patients developed FOG to identify symptoms that may precede…
  • 2017 International Congress

    Investigating the Association between Anxiety and Cognitive Impairment in Parkinson’s Disease: A Descriptive Study

    A. Toft, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, D. Copland, N. Dissanayaka (Brisbane, Australia)

    Objective: This study investigated the relationship between anxiety and cognitive impairment in PD. Background: Anxiety and cognitive impairment are prevalent non-motor complications in PD. The…
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • 2017 International Congress

    Association of pain in Parkinson’s disease with anxiety, depression and sleep quality: a cross-sectional study

    A.Q. Rana, U. Saeed, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: To investigate the association of pain in Parkinson's disease (PD), including its clinical and descriptive subtypes, with anxiety, depression and sleep quality. Background: Pain is a common non-motor…
  • 2017 International Congress

    Depression, anxiety and quality of life in Multiple System Atrophy

    L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…
  • 2017 International Congress

    Understanding the illness experience of people living with Parkinson’s disease: A mixed methods study

    JJ.Y.-Y. Kwok, M.M. AuYeung, H.Y.-L. Chan (Hong Kong, Hong Kong)

    Objective: This study aimed to (i) examine the relationship of psychological distress and HRQoL and (ii) explore the illness experience among people with PD.  Background:…
  • 2017 International Congress

    Internet-based Cognitive Behavioral Therapy for general function in patients with Parkinson’s Disease: A randomized controlled trial.

    M. Kraepelien, R. Schibbye, P. Svenningsson, N. Lindefors, V. Kaldo (Stockholm, Sweden)

    Objective: This study investigates the effect of therapist-guided internet-based cognitive behavioral therapy (ICBT) for general function in Parkinson’s disease (PD) compared to a waitlist. Background:…
  • 2017 International Congress

    Redefining social work for Parkinson’s: the development of a model of care for specialized support in the clinic, community and home

    A. Lemen, LCSW, M. Sweeney, LMSW, V. Luce, LCSW, D. Rayment, LMSW, A. Di Rocco (New York, NY, USA)

    Objective: The development of a dynamic, multimodal social work program model for individuals, caregivers and families living with Parkinson’s disease Background: Patients living with Parkinson’s…
  • 2016 International Congress

    Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus

    A. Benazzouz, C. Delaville, E. Faggiani (Bordeaux, France)

    Objective: To investigate the involvement of combined depletions of dopamine, norepinephrine and serotonin in the manifestation of motor and non-motor deficits and their impact on…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley